IACTA Pharmaceuticals

IACTA Pharmaceuticals is an ophthalmic pharmaceutical company based in California, led by former executives from Allergan, one of the world's leading eye care companies. IACTA currently has six products in development to provide significant market opportunities, two of which are aimed at entering Phase 2 clinical trials. IACTA assumes a research and development role, leveraging expertise and technology acquisition partnerships to develop a late-stage product portfolio. The company is developing ophthalmic drugs with novel mechanisms of action to treat diseases with severe unmet needs, while also optimizing the delivery of existing drugs to target tissues using innovative delivery platforms.